Filters
Results 1 - 10 of 79
Results 1 - 10 of 79.
Search took: 0.032 seconds
| Sort by: date | relevance |
No abstract available
Journal
British Journal of Radiology; ISSN 0007-1285; 
; v. 53(626); p. 171-172
; v. 53(626); p. 171-172
[en] Radiation biology has had an important impact on clinical radiation therapy by providing a rationale for implementation of new treatment strategies and for clinical concepts or practices thereby increasing their acceptance. The observed rather narrow range of D0 and n values for mammalian cells contributed to successful trials of radiation treatment of several ''radiation-resistant'' tumors, e.g., carcinoma of prostate, color-rectum, and sarcoma of soft tissue. Attention of clinicians was forcibly directed to assessment of local results (local failure, treatment complications) and not merely survival at 5 years by the extensive literature of cell survival curves (in vivo and in vitro) and dose-response assays on normal and tumor tissues. Upon these same laboratory results a scientific rationale was developed for use of shrinking field technique, low dose for subclinical disease, and the combination of moderate dose radiation therapy and conservative surgery. The entire area of clinical research into altered dose fractionation schedules is based upon research on cell proliferation kinetics and repair of radiation damage. The understanding that the time for complete regression of tumor depends not only upon cell kill but also on the pattern of cell proliferation of the progeny of lethally irradiated cells and the abundance of stroma provided a basis for accepting patients with slowly responding tumors for treatment. There remains a wide field of need in research in this area as even today a large proportion of patients who die of cancer die with their cancer uncontrolled at the primary site
Journal
Radiation Research; ISSN 0033-7587; ; v. 94(1); p. 10-40
; v. 94(1); p. 10-40
[en] There has been a substantial and intense interest by laboratory and clinical investigators in the development of agents which modify the response of tissue to radiation differentially so as to increase the effect on tumor relative to normal tissue. These have included efforts to increase the response of tumor or to decrease response of normal tissue. The plan of this presentation is to: define radiation response modifiers; consider the impact of response modifiers on dose response curves; comment on problems inherent in assessment of results of clinical trials of response modifiers; and review briefly results of several trials of: sensitizers of hypoxic cells (hyperbaric oxygen, chemical sensitizer), pyrimidine analogs, and protectors
Journal
International Journal of Radiation Oncology, Biology and Physics; ISSN 0360-3016; ; v. 12(1); p. 101-108
; v. 12(1); p. 101-108
[en] The combination of radiation and surgery is being employed increasingly in preference to radical surgery alone or high radiation dose alone in the treatment of malignant epithelial and mesenchymal neoplasms. The basis for this interest is that the scope of the surgery and/or the radiation dose level are less than if either were employed alone. A reduction in treatment related morbidity, improved cosmetic and functional status, and in some instances a lower local failure rate may be achieved by this approach. The rationale for combining radiation and surgery is that radiation at moderate dose levels is effective in the eradication of microscopic extensions of tumor beyond the clearly obvious mass while the surgery (usually more conservative) removes the principal mass
Journal
| 1 | 2 | 3 | Next |